相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
William J. Sandborn et al.
GASTROENTEROLOGY (2014)
Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis
Remo Panaccione et al.
GASTROENTEROLOGY (2014)
Feasibility of Endoscopic Assessment and Treating to Target to Achieve Mucosal Healing in Ulcerative Colitis
Guillaume Bouguen et al.
INFLAMMATORY BOWEL DISEASES (2014)
Validation of the Ulcerative Colitis Colonoscopic Index of Severity and Its Correlation With Disease Activity Measures
Sunil Samuel et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Validation of Endoscopic Activity Scores in Patients With Crohn's Disease Based on a Post Hoc Analysis of Data From SONIC
Marc Ferrante et al.
GASTROENTEROLOGY (2013)
Reliability and Initial Validation of the Ulcerative Colitis Endoscopic Index of Severity
Simon P. L. Travis et al.
GASTROENTEROLOGY (2013)
A New Rapid Quantitative Test for Fecal Calprotectin Predicts Endoscopic Activity in Ulcerative Colitis
Triana Lobaton et al.
INFLAMMATORY BOWEL DISEASES (2013)
52-Week Efficacy of Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis Who Failed Corticosteroids and/or Immunosuppressants
Walter Reinisch et al.
INFLAMMATORY BOWEL DISEASES (2013)
Prognostic Value of Serologic and Histologic Markers on Clinical Relapse in Ulcerative Colitis Patients With Mucosal Healing
Talat Bessissow et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease
Geert D'Haens et al.
INFLAMMATORY BOWEL DISEASES (2012)
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis
Axel Dignass et al.
JOURNAL OF CROHNS & COLITIS (2012)
Mucosal Healing Predicts Late Outcomes After the First Course of Corticosteroids for Newly Diagnosed Ulcerative Colitis
Sandro Ardizzone et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis
Jean Frederic Colombel et al.
GASTROENTEROLOGY (2011)
Results of the 2nd part Scientific Workshop of the ECCO (II): Measures and markers of prediction to achieve, detect, and monitor intestinal healing in Inflammatory Bowel Disease
Marco Daperno et al.
JOURNAL OF CROHNS & COLITIS (2011)
Newly Developed Antibiotic Combination Therapy for Ulcerative Colitis: A Double-Blind Placebo-Controlled Multicenter Trial
Toshifumi Ohkusa et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Importance of Mucosal Healing in Ulcerative Colitis
Gary R. Lichtenstein et al.
INFLAMMATORY BOWEL DISEASES (2010)
Long-term Follow-up of Ulcerative Colitis in the Chinese Population
Dorothy K. L. Chow et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab
William J. Sandborn et al.
GASTROENTEROLOGY (2009)
Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial
W. Kruis et al.
GUT (2009)
Open-Label Study of Adalimumab in Patients with Ulcerative Colitis Including Those with Prior Loss of Response or Intolerance to Infliximab
Waqqas Afif et al.
INFLAMMATORY BOWEL DISEASES (2009)
Increased Efficacy of Delayed-Release Mesalamine 4.8g/D (800mg Tablet) in Patients Previously Diagnosed with Ulcerative Colitis (UC)
William J. Sandborn et al.
GASTROENTEROLOGY (2009)
Clinical role of calprotectin assay in determining histological relapses in children affected by inflammatory bowel diseases
A. Diamanti et al.
INFLAMMATORY BOWEL DISEASES (2008)
Mucosal healing in inflammatory bowel disease: Results from a Norwegian population-based cohort
Kathrine Frey Froslie et al.
GASTROENTEROLOGY (2007)
Once-daily, high-concentration MMX mesalamine in active ulcerative colitis
Michael A. Kamm et al.
GASTROENTEROLOGY (2007)
Factors associated with disease evolution in Greek patients with inflammatory bowel disease
Constantinos Chatzicostas et al.
BMC GASTROENTEROLOGY (2006)
Budesonide foam versus budesonide enema in active ulcerative proctitis and proctosigmoiditis
V Gross et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Infliximab for induction and maintenance therapy for ulcerative colitis
P Rutgeerts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: The ASCEND II trial
SB Hanauer et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Treatment of ulcerative colitis with a humanized antibody to the α4β7 integrin
BG Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Azathioprine or methotrexate in the treatment of patients with steroid-dependent or steroid-resistant ulcerative colitis: results of an open-label study on efficacy and tolerability in inducing and maintaining remission
OA Paoluzi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Oral beclometasone dipropionate in the treatment of active ulcerative colitis: a double-blind placebo-controlled study
F Rizzello et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Does Graves' disease during puberty influence adult bone mineral density?
G Radetti et al.
HORMONE RESEARCH (2002)
A double-blind comparison of balsalazide, 6.75 g, and sulfasalazine, 3 g, as sole therapy in the management of ulcerative colitis
JC Mansfield et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis
A Bitton et al.
GASTROENTEROLOGY (2001)
A reproducible grading scale for histological assessment of inflammation in ulcerative colitis
K Geboes et al.
GUT (2000)
分享论文
